Proactive Investors - Run By Investors For Investors

Canadian medical marijuana company Aphria pegs C$225mln war chest to build new facilities

Aphria to build a C$55mln cannabis extraction center in Ontario as Canada gears up to begin legal pot sales by late summer
Cannabis
Canada's Senate voted to pass Bill C-45 — landmark legislation to legalize recreational marijuana

With the Canadian Senate voting ‘Yes’ Thursday to legalize recreational cannabis, Canadian medical marijuana growers are all chasing first-mover advantage and global expansion. Aphria Inc (TSE:APH) was quick off the block with its announcement Thursday that it will make a big investment in Leamington, Ontario.

The company, which has an eye on global expansion, said it is raising C$225mln to pay for new cannabis facilities in Canada, as well as potential acquisitions. Some of the funds will be plowed into a new C$55mln extraction facility in Leamington, Ontario that will use a variety of methods to produce concentrated cannabis products like oils.

READ: A game-changing vote: Canadian senate votes ‘Yes’ to legalize recreational cannabis

"The Extraction Centre of Excellence will give Aphria a significant competitive advantage in cannabis concentrates, which are expected to be a significant product category," said Aphria CEO Vic Neufeld, in a statement. "This facility will be the centre of industry-leading R&D and commercial production of next generation cannabis concentrate products."

The Canadian firm also said it plans to spend an additional C$20mln at its Aphria Diamond facility to increase capacity by 20 tonnes annually and allow for alternative growing techniques, and C$10mln to add 10 tonnes of capacity to its Aphria One operation.

Canadian producers like Aphria are pushing really hard to take that first-mover advantage as the country gets all set to legalize marijuana sales. The Canadian Senate voted Thursday to pass Bill C-45 — the landmark legislation to legalize recreational marijuana — by a vote of 56 to 30, with one abstention.

Aphria is one of Canada's low-cost producers and sells medical cannabis. It is in Leamington, Ontario, the greenhouse capital of Canada.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full APHA profile View Profile

Aphria Timeline

Related Articles

muffins and cannabis
November 29 2018
Dehydratech is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time
cannabis leaf
May 08 2019
The company plans to leverage its portfolio of brands as well as its distribution network of more than 39,000 European pharmacies to maximize margins and profitability
cannabis flower
April 26 2019
The company's footprint continues to grow as it focuses on becoming a globally recognized house of brands with a broad portfolio of clients across North America
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use